BCR/ABL, Translocation 9;22, FISH (D-FISH)
Method Description Describes how the test is performed and provides a method-specific reference
D-FISH can be performed on 1 mL of bone marrow aspirate or 5 mL of blood collected in sodium heparin. DNA probes that map to and span the common breakpoints of the ABL1 oncogene at 9q34 and the BCR at 22q11.2 are hybridized to the chromosomes of cells from bone marrow or peripheral blood. These probes are visualized by fluorescent microscopy. Normal metaphase and interphase cells have 2 red signals signifying the hybridization of the ABL1 probe to both chromosomes 9 at band 9q34, and 2 green signals signifying the hybridization of the BCR probe to both chromosomes 22 at band 22q11.2. Cells with a t(9;22)(q34;q11.2) have 1 red signal from the normal chromosome 9 at 9q34 and 1 green signal from the normal chromosome 22 at 22q11.2. In the abnormal chromosomes, parts of the hybridization sites for each of these probes have translocated to the other chromosome. Thus, 2 signals representing a fusion of red and green signals are observed (D-FISH); 1 on the abnormal chromosome 9 and the other on the abnormal chromosome 22. A small percentage of normal interphase cells will appear to have fusion signals because of the coincidental juxtaposition of 9q34 and 22q11.2.(Dewald GW, Wyatt WA, Juneau Al, et al: Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia. Blood 1998;91:3357-3365; Buno I, Wyatt WA, Zinsmeister AR, et al: A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia. Blood 1998;92:2315-2321)
Supplemental Report Indicates whether the report includes an additional document with charts, images or other enriched information
Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Samples processed Monday through Sunday. Results reported Monday through Friday, 8 a.m.-5 p.m. CST.
Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.
Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result
Specimen Retention Time Outlines the length of time after testing that a specimen is kept in the laboratory before it is discarded
Performing Laboratory Location The location of the laboratory that performs the test